ROTHSCHILD & CO ASSET MANAGEMENT US INC. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 208 filers reported holding PTC THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROTHSCHILD & CO ASSET MANAGEMENT US INC. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$8,337,000
+32.6%
136,604
+1.6%
0.11%
-5.3%
Q3 2020$6,285,000
-4.6%
134,439
+3.6%
0.11%
+16.5%
Q2 2020$6,585,000
+15.3%
129,787
+1.4%
0.10%
+9.0%
Q1 2020$5,710,000
+549.6%
127,994
+599.7%
0.09%
+888.9%
Q4 2019$879,000
+35.9%
18,293
-4.4%
0.01%
+28.6%
Q3 2019$647,000
-15.9%
19,140
+11.9%
0.01%
-12.5%
Q2 2019$769,000
+17.9%
17,097
-1.3%
0.01%
+14.3%
Q1 2019$652,000
-40.1%
17,325
-45.3%
0.01%
-46.2%
Q4 2018$1,088,000
-18.1%
31,692
+12.2%
0.01%
-7.1%
Q3 2018$1,328,00028,2530.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders